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Objective: Alopecia aretea is associated with an increase in free radicals causing damage to hair follicles. Superoxide dismutase (SOD) with 
sufficient penetration through hair follicles, can prevent their death by its strong antioxidant effects. SOD with high molecular weight underwent 
limitation in follicular delivery. The aim of this study was the improvement of SOD localization into hair follicles. 
ABSTRACT 
Methods: SOD-loaded niosomes were prepared by thin layer hydration method and were used as a vehicle for delivery to hair follicles through 
guinea pig skin and the synthetic membrane. Particle size, entrapment efficiency, drug release, and permeability parameters through hairly and 
non-hairly pig skin compared with a synthetic membrane were evaluated.  
Results: Niosomes demonstrated 152-325 nm particle size and the SOD burst and sustained release from niosomes were mainly controlled by 
diffusion and dissolution phenomena. SOD was protected against degradation by niosomes and after six months, enzyme content and activity 
decreased less than 5%. In comparison with free SOD, niosomes increased SOD affinity to penetration through follicles by interaction with sebum. 
Likewise, niosome's characters such as type of surfactant, solid lipid/liquid lipid ratio played critical roles on SOD deposition on hair follicles.  
Conclusion: Synthetic membrane and hairy guinea pig skin demonstrated similar barrier property against free-SOD thereby implying that free SOD 
does not interact with guinea pig sebum. Niosomes can introduce a suitable carrier for SOD localization into the hair follicles.  
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Alopecia areata (AA) isa hair loss disease resulting from an 
inflammatory, autoimmune disorder that is associated with damage 
to hair follicles. AA is accompanied by an increase in free radicals 
such as reactive oxygen species (ROS) and nitric oxide; and a 
decrease of the antioxidant activity that is provided by enzymes 
such as superoxide dismutase (SOD). Along the course and increased 
severity of the disease, protective mechanisms of antioxidant 
enzymes will be inadequate thereby resulting in oxidative damage to 
cellular components [1-6]. SOD has an important role in the defense 
against free radical damage that catalyzes the highly reactive 
dismutation superoxide anion to oxygen and the less reactive 
hydrogen peroxide [7]. 
SOD also helps to carry nitric oxide to the hair follicles which by 
acting as a vasodilator benefits hair follicles by allowing increased 
blood flow [8].  
Targeted SOD delivery may enhance therapeutic approaches to the 
treatment of AA. Bulge region and follicular papilla were introduced 
as two major targets in hair follicles for AA treatment [9]. Drug 
delivery to these sites may be limited by structural, physical and 
chemical barriers [10]. Penetration through hair follicles is highly 
dependent upon the hydrophilic and lipophilic properties and 
particle size of vehicles and can be improved by using suitable 
vehicles. Emerit et al. showed that SOD applied to the skin surface 
penetrates through the follicular appendages as well as the 
unbroken stratum corneum [11]. SOD, however, is a large molecule 
with high aqueous solubility and cutaneous absorption is a major 
concern when it is considered for topical treatment [12]. In recent 
years many efforts have been made to enhance drug deposition to 
hair follicles using different drug delivery systems such as niosomes 
[13]. Niosomes are non-ionic surfactant based vesicle that 
demonstrating a slow pattern of release [14]. Niosomes have several 
advantages such as low cost, great chemical stability, high 
entrapment capacity and low particle size that could provide 
increased drug permeation and localization into the skin [15-18].  
Tabakhian and his colleagues have studied the in vitro and in vivo 
skin application of finasteride loaded in niosomes to increase drug 
concentration in pilosebaceous [19].  
Manosroi and colleagues reported that optimal follicular delivery was 
occurred by niosomes prepared by poly-unsaturated fatty acid with 
zeta potential around-36 mV and particle size of about 200 nm [14].  
A number of studies have evaluated the difference between follicle-rich 
versus follicle-free skin models using both hairy and hairless animal skin. 
Human skin availability is limited and so animal models such as a mouse, 
rat, pig, guinea pig, and snake have been used as an alternative in 
follicular drug delivery studies [20]. Because of availability, low cost and 
ease of handling, mouse, rat, and guinea pig skin are the most commonly 
used in in vitro and in vivo percutaneous absorption studies [21]. 
Anderson et al. evaluated percutaneous absorption of [14] C ring-labeled 
hydrocortisone, testosterone, and benzoic acid through guinea pig skin 
and compared the results with previous human data [22]. They reported 
that the absorption of hydrocortisone and benzoic acid was similar to 
human skin; however, testosterone was absorbed in a greater rate in 
guinea pigs compared to humans. Synthetic membranes are used as 
models for follicular and transdermal absorption and demonstrated 
several advantages [23, 24]. 
In this study, we followed two main aims. At first, the aim of this 
research was an evaluation of the ability of niosomes for site-specific 
delivery of SOD into hairy skin. Secondly, we tried to introduce 
synthetic membrane as follicular rout imitation model. Permeability 
studies with synthetic membranes instead of in vivo and in vitro 
experiments through human and animal skins may overcome the 
problems associated with these studies.  
MATERIALS AND METHODS 
Materials  
Zn, Cu-SOD from bovine erythrocytes, SOD assay kit, and Bradford 
reagent were purchased from Sigma-Aldrich (USA). Cholesterol, egg 
lecithin, oleic acid, and sodium lauryl sulfate (SLS) were provided from 
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Sigma-Aldrich and oleoyl macrogol-6 glycerides: Labrafil SM 1944 C 
(Labrafil) was gifted from Gattefosse [France). Methanol and 
chloroform  were  purchased from Merck (Germany). Bovine serum 
albumin (BSA) was purchased from Sigma-Aldrich. All other materials 
and solvents used in this study were of analytical grade. The synthetic 
membrane was made by Dorsa Behsaz Co (Tehran, Iran). For this 
purpose, human scalp hairs including 90 hair follicles with 45 µm per 
cmP2Psuch as actual human condition obtained from females were fixed 
in a chamber and filled with resin at room temperature.  
Animals  
Female adult guinea pigs ranging in size from 600-800 g with the 
age of 20-22 w were purchased from Razi Institute (Iran). Animals 
were kept for 5 d of acclimatization, and given a standard diet and 
water and were then treated according to the principles for the care 
and use of laboratory animals. Approval for the studies was given by 
the Ethical Committee of the Ahvaz Jundishapur University of 
Medical Sciences (approval number: N-104). The guidelines 
followed were those laid down by the National Academy of Sciences 
and published by the National Institutes of Health (U. S. Department 
of Health and human services, Office of laboratory animal welfare).  
Experimental design for preparation of niosomes  
Several parameters influence on final properties of niosomes and 
permeation through hair follicles. The full-factorial design was used 
concerning with 3 variables at 2 levels as experimental design in this 
study. Solid lipid/liquid lipid w/w ratio (S. L/l. L), lipid/surfactant 
w/w ratio (L/S) and type of surfactant (T. S) were chosen as 
independent variables (table I). Cholesterol and oleic acid were used 
as solid and liquid lipids, respectively. Labrafil as non-ionic and 
sodium Lauryl sulfate as an anionic surfactant was chosen for the 
evaluation of the effect of charge on the follicular drug delivery 
ability of niosomes.  
Independent parameters and their levels were chosen based on 
the preformulation study. Dependent variables include SOD 
entrapment efficiency, noisome size, drug release and permeation 
parameters through guinea pig skin and synthetic membrane. The 
effects of independent variables on dependent variables were 
evaluated by calculation of correlation coefficient (r P2 P) (explained 
variation/total variation), adjusted r P2 P (one type of r P2 P that 
evaluates regression model's explanatory power) and F-test (in 
regression compares the fits of different linear models). The 
intensity of variables interaction on each response was estimated 
through simultaneous multiple regression with Minitab 16 
software. A total of eight experimental runs were generated for the 
evaluation of the main effects and possible interactions. 
Accordingly, eight samples, with 0.5% W/V surfactan1 or 
surfactant2, with 8 mg of cholesterol as solid lipid, and varying in 
the amount of oleic acid (0.21-0.44 mg) and lecithin (0.21-0.44 
mg) as liquid lipids were prepared (formulations F1-8, table II). 
  
Table 1: Independent variables considered in experimental design and their levels 
Independent variable Low level High level 
S. L/l. L 9 19 
L/S 10 20 
T. S Labrafil Sodium lauryl sulfate 
 
Niosome preparation 
Niosomes were prepared by the thin-film hydration method. 
Accurately weighed quantities of the surfactant (SLS or Labrafil), 
cholesterol, lecithin, and oleic acid were dissolved in chloroform and 
methanol (2:1) in a round bottom flask. The organic solvents were 
removed under vacuum in a rotary (IKA RV05, Germany) evaporator 
at 55 °C for 30 min and 200 rpm to form a thin film on the wall of the 
flask. This was kept under vacuum for 2 h to ensure total removal of 
trace solvents. After 2 h, the dry lipid film was hydrated with 10 ml 
of SOD solution (50 Unit/ml in phosphate buffer, pH 7.4) with the 
resulting dispersion undergoing sonication in a bath-type sonicator 
(T-710 DH-ELMA, Germany) in 3 cycles of 3 min “on”/5 min “off” 
leading to the reduction in particle size of formed niosomes [25]. 
SOD activity assay  
The activity of SOD was determined by the ability of SOD in 
converting superoxide radicals to hydrogen peroxide that causes 
inhibition in indicator oxidation and in result inhibits color 
formation [26]. 
Protein assay method 
Total protein concentration was determined by Bradford method 
with BSA as standard protein.  
SOD entrapment efficiency (EE%) 
The amount of SOD entrapped in the niosomes was measured by an 
indirect method. In the indirect method, the calculation was done 
based on the difference between the total amount of SOD applied in 
the niosomal formulation and the amount of non-entrapped SOD 
remaining in the supernatant. SOD niosomal formulations were 
centrifuged at 15700× g for 60 min at 4 °C, to separate the 
supernatant including the unloaded enzyme. SOD concentration in 
the supernatant was determined with a UV spectrophotometer at 
595 nm by the Bradford method. The percentage of SOD entrapped 
in the niosome calculated by the following equation. This process 
was repeated thrice to completely free SOD was removed [27].  
100]
drug total
spernatantin  drug - drug total [ entrapment drug  % ×=
 ……. [1] 
Particle sizes and zeta potential measurement 
The mean size of niosomes was determined at 25°C by laser light 
diffractometry using Malvern Zetasizer Nano ZS (Malvern 
instrument, UK). Each niosomal formulation was diluted (20x) with 
phosphate buffer (pH 7.4) before the experiment was carried out. 
Each sample was measured five times. The zeta potential of 
niosomes was determined using phase analysis light scattering. 
Sample preparation was the same as for particle size measurements. 
The length of time of analysis was 60 seconds. Each sample was 
measured five times.  
Atomic force microscopy (AFM) 
On the other hand, AFM visualization (LEO, Germany) presents 
information about the shape and size of niosomes. For this purpose, 
Atomic Force Microscopy (JPK, Nanowizaerd II, Germany) was used. 
5 µl of the niosome solution was loaded in the center of a split mica 
disk. The image was set to tapping mode and the average scanning 
speed was 5 Hz.  
Physical stability of niosomes 
All formulations were stored at 2-8 °C for 6 mo and niosome size, 
Zeta potential, enzyme activity and protein content, appearance, and 
drug release were assessed. The results were correspondingly 
compared with the values of freshly prepared samples.  
In vitro release studies 
In vitro SOD release was assessed by the dialysis technique. For each 
formulation, 10 ml was centrifuged at 15700× g for 25 min at 4 °C to 
separate niosomes. The pellet was washed twice with water, 
centrifuged, dried and then suspended in 5 ml of distilled water. The 
niosome suspension was then placed in cellulose acetate dialysis 
tubes (10 kDa, Sigma-Aldrich) which were immersed in 200 ml of 
phosphate buffer (pH 7.4) at 37°C that was magnetically stirred at 
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50 rpm. At predetermined time intervals (0.5, 1, 2, 3, 4, 5, 6, 7, 8, 24 
and 48h), 0.5 ml of sample was removed from receptor 
compartment for spectrophotometric determination and replaced 
immediately with an equal volume of fresh receptor medium. 
Samples were analyzed for protein content with Bradford reagent 
and SOD activity with SOD assay kit. In this experiment, an aqueous 
solution of SOD with the same concentration was used as control. 
Permeation study of SOD loaded niosomes through the 
synthetic membrane and guinea pig skin  
Wahlberg substantiated the value of guinea pig abdominal skin as 
hairy and ear skin as a non-hairy animal model for follicular 
permeation studies [28]. Therefore in this study, permeation studies 
were performed using hairy and non-hairy guinea pig skin and a 
synthetic membrane fabricated by Dorsa Behsaz Co (Tehran, Iran). 
Static Franz diffusion cells were used and hairy and non-hairy skins 
were mounted between donor and receptor phases. All skin and 
synthetic membranes provided 3.49 cm2 surface area. Synthetic hair 
membrane made by epoxy resin, including 90 human hair follicles 
with 45 µm per each cm2as seen in humans [29]. The donor 
compartment was filled with SOD-loaded noisome formulations (50 
U/ml) while the receptor compartment was filled with 25 ml 
phosphate buffer (pH 7.4). The diffusion cell was placed and 
clamped in a water bath at 37±0.5°C placed on a magnetic stirrer 
with a heater. The receptor media were magnetically stirred at 100 
rpm. Permeation study extended until 5-folds of lag time that was 
calculated in the preformulation study (i.e. sampling was continued 
for 48 h). At predetermined time intervals, 2 ml of media was 
removed from the receptor compartment for spectrophotometric 
determination and replaced immediately with an equal volume of 
fresh receptor medium. Samples were analyzed for protein content 
with Bradford reagent and SOD activity with SOD assay kit. The 
solution of SOD in buffer phosphate (pH 7.4]) was used as control. 
Lipids in hairy and non-hairy guinea pig skin were extracted by a 
method described by Wertz and Downing
Statistical methods 
 (first with methanol and 
then with chloroform/methanol 2:1 at room temperature) [30] and 
permeability parameters before and after lipid extraction were 
compared to get clear information about the role of sebum on drug 
delivery into the follicles. 
The One-Way (ANOVA) Analysis of Variance and unpaired t-test was 
used. In addition, to study the relationship between variables and 
responses, multiple regressions were carried out. The p-value of 
0.05 and less was considered statistically significant. Data analysis 
was done with Microsoft Excel and Minitab 16.  
RESULTS AND DISCUSSION  
Niosome characterization 
The physicochemical and biopharmaceutical characteristics of 
niosomes prepared based on factorial experimental design is shown 
in table 2. A total of eight experimental runs were generated for the 
evaluation of the main effects and possible interactions. Accordingly, 
eight formulations were prepared (F1-8). 
-Niosome particle size and zeta potential 
Niosome size of freshly prepared formulations varied between 152-
325 nm and as seen, the smallest and the biggest sizes belong to 
formulation F1 and F6, respectively. Formulation F1 is made by high 
levels of S. L/l. L, L/S ratios and Labrafil as surfactant while 
formulation F6 consisted of S. L/l. L=9 and L/S= 20. Regression 
analysis of results showed the lowest size was obtained by labrafil 
and S. L/l. L= 19. The mathematical model indicated a significant 
correlation between the surfactant type and S. L/l. L variables and 
niosome size. The results of ANOVA as shown in table 2 indicated 
that the model was significant for niosome size.  
Drug delivery into the hair follicle depends on different factors such 
as particle size. Schaefer et al. found that fluorescent polystyrene 
beads between 5 to 7 µm in diameter were deposited deep in the 
hair follicle whereas smaller or larger beads localized in the stratum 
corneum and skin surface [31]. Lademann et al. reported that 
particle sizes between 300-600 nm penetrate more efficiently and 
deeper into the hair follicles than non-particulate substances [32]. 
Also, Vogt et al. found that particles in the size around of 750 nm 
remain in the superficial parts of the infundibulum of terminal 
human hair while particles sized 40 nm penetrate deeper into the 
follicular duct [33].  
Therefore, it seems that niosomes that were prepared in this study 
with particle sizes around 150-330 nm increased SOD partitioning 
and penetration into the hair follicles.  
On the other hand, zeta potential values were between-25.3 to-37.7 
mV that mainly affected by the type of surfactant and higher zeta 
potential was obtained by using SLS as a surfactant. SLS is an anionic 
surfactant usually a mixture of sodium alkyl sulfate that provides 
negative charges. Labrafil is a non-ionic surfactant that librates less 
negative charges compared to SLS. On the other hand, lecithin in 
pH=7.4 demonstrates a slight negative charge.  
- SOD EE% and activity 
Niosomes illustrated SOD EE% between 49-90%, a value well suited 
for hydrophilic compounds. The correlation between independent 
variables and EE% is shown in fig. 1. The results of ANOVA (table 3) 
demonstrated the significance of model for EE%. EE% was affected 
by surfactant properties such as hydrophilic-lipophilic balance 
(HLB). Maximum SOD entrapment provided by Labrafil and SLS was 
90% and 74%, respectively. This difference is significance (P=0.011) 
and mainly depend on surfactant HLB. It seems that Labrafil with 
HLB=4 in comparison with SLS with HLB=40 increased more SOD 
solubility in the bilayer membrane. Based on method preparation, 
multilamellar vesicle (MLV) is probably formed consisting of several 
lamellar phase lipid bilayers [34]. Although hydrophilic molecules 
such as SOD mainly are located in the aqueous core, the appropriate 
surfactant can increase SOD entrapment into the bilayer. That means 
protein entrapment in MLV is mainly dependent on solubility in the 
lipid bilayer. Therefore Labrafil cased higher SOD solubility in 
bilayer membrane and higher protein entrapment compared to SLS 
with the hydrophilic property. In this study, two surfactants with 
completely different HLB have been chosen to articulate the role of 
surfactant properties on drug loading into the niosomes. Different 
vehicles such as poly (DL-Lactide-Co-Glycolide) (PLGA) 
microsphere, alginate-chitosan microsphere [35], cationic niosome 
[36] and mucoadhesive chitosan-coated niosome [20] have been 
used as SOD vehicle. The highest and lowest SOD % entrapments 
were 92% and 17%, provided by alginate-chitosan microspheres 
and cationic niosomes, respectively. The entrapment in chitosan-
coated niosome (64%) was more than cationic niosomes (17%). It 
seems that SOD solubility, particle size, SOD-excipients interaction 
and physical state of carriers play a critical role in determining the 
extent of entrapment. Microspheres with solid-state provided more 
SOD entrapment compared with niosomes. In this study, niosomes 
were prepared by labrafil, provided EE% equal to alginate-chitosan 
microspheres. In the other hand, in different studies, liposomes with 
a similar structure to niosomes have been used for SOD loading and 
EE% 20-40% was reported [37, 38]. It seems that using of suitable 
surfactant in niosomes, significantly increased SOD EE% compared 
with liposomes.  
In formulations F4 and F8 immediately after preparation, the 
activities of SOD loaded in niosomes were 73.3% and 67.5%, 
respectively. The activity of SOD in aqueous solution with the same 
concentration was 84.5%. It can be concluded there was little 
activity loss during the production procedure. The evaluation of the 
effect of Triton X-100 on SOD activity demonstrated a decrease in 
enzyme activity of less than 5%. 
In vitro SOD release studies  
In vitro release profiles of SOD from niosomal formulations are 
shown in fig. 2. The percentage of SOD released after 30 min (%R-
0.5) and 48 h (%R-48) were chosen for the evaluation of burst and 
delayed-release, respectively. Regression analysis of results shows 
a significant correlation between all independent variables and 
%R-0.5 in this manner that higher %R-0.5 was provided by 
formulations including Labrafil as a surfactant, higher S. L/l. L 
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and lower L/S ratios. Likewise, %R-48 was 78.9-91.8% 
(formulation F1 and F4, respectively). Higher %R-48 was obtained 
in formulations using Labrafil as a surfactant. Also significant (p 
= 0.015) and indirect correlation was found between zeta 
potential value and %R-48. Release pattern suggests burst release 
with all formulations especially F4. This means more than 30% of 
the total loaded enzyme released fast after 30 min. Previously, 
SOD burst release from microspheres has been reported [27]. But 
SOD didn’t show burst release from PLGA and chitosan-alginate 
microspheres and only 43.7% of loaded SOD released after 15 d 
[35]. This burst release is in accordance with the hydrophilic 
properties of SOD with high affinity for aqueous bulk phase. Some 
parts of SOD that incorporated in the aqueous core show a 
sustained release pattern that previously it was observed for SOD-
loaded microspheres. 70-80% of enzymes were released from 
microspheres within the first day, with total release complete by 
4-8 d [27]. In comparison between microspheres and niosomes 
based on the present study, it can be concluded that 
microspheres presented a more sustained release profile than 
niosomes. The solids state of microspheres compared with liquid 
state of niosomes may is the reason for a SOD sustained release 
profile. 
 
Table 2: Sample sequence from the design of experiments and corresponding niosome size, entrapment efficiency and activity of SOD 
loaded in niosomes 
SOD activity [%]  EE%  Mean size [nm] (L/S) ratio (S. L/l. L) ratio Zeta potential [mv] Surfactant Batch  
68.4±7.9 59.1±6.3 152±11 20 19 -30 Lab F1 
71.5±9.4 75.44±4.8 305±20 20 19 -37.2 SLS F2 
69.2±5.8 49.11±3.5 190±8 10 19 -25.3 Lab F3 
71.4±8.3 89.6±7.1 244±16 10 19 -37.7 SLS F4 
73.3±8.8 74.5±8.2 240±18 20 9 -28.8 Lab F5 
70.1±5.4 82.2±5.4 325±33 20 9 -34.8 SLS F6 
71.5±6.6 56.1±5.5 290±19 10 9 -30.5 Lab F7 
67.5±7.1 80.1±6.8 312±25 10 9 -33.2 SLS F8 
Values are mean±SD [n = 5]., Lab,Labrafil; SLS: Sodium saurylsulphate, S. L/l. L: solid lipid/liquid lipid ratio, EE%: entrapment efficiency 
 
Table 3: Summary of ANOVA for niosome size and SOD EE [%] in niosomes prepared by 23factorial design 





























Fig. 1: Surface plots of correlations between independent variables and SOD entrapment efficiency (EE%) 
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Fig. 2: Release profiles of SOD from niosome formulations F1-8 in phosphate buffer at pH 7.4. Data are expressed as the mean±SD (n = 5) 
 
SOD-loaded niosome permeation through guinea pig skin and 
synthetic membrane 
The cumulative activity of SOD permeated across guinea pig skin after 
1 (%A1) and 48 (%A48) hours are shown in table 4. Amount of 
protein permeated through hairy and non-hairy guinea pig skin before 
and after lipid extraction and through the synthetic membrane are 
presented in fig. 3 All membranes were treated with formulations F1, 
F8 and SOD solution of the same concentration. F1 and F8 
formulations present highest and the lowest amount of independent 
variables (table 1), respectively. Therefore formulation F1 with low 
particle size and EE% together formulation F8 with the high particle 
size and EE% were selected for permeation study. Based on these 
results, different comparisons were applied that are described below. 
- Comparison between hairy and non-hairy guinea pig skin 
The amount of SOD permeated (%) after 1 h (%P1) and 48 h (%P48) 
across hairy and non-hairy guinea pig skins after application of F1 and 
F8 formulations and SOD solution were calculated and compared. The 
arrangement based on %P1 and %P48 presented below:  
%P1: F1 and F8 in hairy skin>SOD solution in hairy skin>F1 and F8 
in non-hairy skin>SOD solution in non-hairy 
%P48: F1 and F8 in hairy skin>SOD solution in hairy skin>F1 in non-
hairy skin>SOD solution in non-hairy>F8 in non-hairy skin  
Based on these results different conclusion can be presented:  
-%P1 and %P48 in hairy skins were significantly bigger for both 
niosomal formulations (F1 and F8) and free solution in comparison 
to non-hairy guinea pig skins. Both formulations increased SOD 
affinity fora follicular pathway that was more than SOD solution and 
no significant difference was found between F1 and F8. It means that 
particle size and entrapment ratio were not critical parameters for 
increasing SOD delivery into the follicles. Therefore, the main route 
for SOD permeation through guinea pigskin is a follicular pathway 
that is in accordance with its high molecular weight and hydrophilic 
nature. The importance of follicular pathway for proteins as 
hydrophilic high molecular weight compounds has previously been 
reported [39]. Nano-sized drug delivery systems demonstrate some 
advantages for drug delivery via the follicles. Nanoparticles can 
aggregate in the follicular opening and penetrate through the follicle 
duct and act as a reservoir [40]. The sebaceous glands open into the 
lower infundibulum of the hair follicle and by sebum secretion 
create a lipid-enriched environment. Drug penetration and 
deposition in hair follicles depend on the interaction between a drug 
and its carrier with sebum [41]. Therefore, the lipid carriers such as 
niosomes, solid lipid nanoparticle, and nanoemulsions are efficient 
drug carriers for sebum interaction and accumulation in hair 
follicles. The lipid state of niosomes facilitates sebum interaction and 
penetration across the hair follicles [42]. Therefore, to prove the 
above-mentioned hypothesis, %P1 and %P48 after lipid extraction 
were estimated through hairy and non-hairy guinea pig skins. 
Results indicated that after lipid extraction % P1 and % P48 reduced 
significantly in comparison with prior to lipid extraction. This means 
that interaction between niosomes and sebum plays a critical role in 
SOD accumulation in hair follicles. The reduction in %P1 and %P48 
after lipid extraction for both niosomal formulations were more than 
for SOD in solution. In conclusion, niosome formulations increased 
SOD partitioning into follicles by interaction with sebum.  
-The values of %P1 and %P48 for both niosomal formulations were 
significantly higher than those for SOD solution in hairy skin models. 
But in non-hairy skin, the value of %P48 after application of SOD 
solution was lower than F1 and higher than F8. It means that in non-
hairy skin, early hours after application both formulations increased 
SOD partitioning into the skin more than SOD solution that is in 
accordance with its hydrophilic property. But after several hours, 
SOD permeation through non-hairy skin (%P48) was affected by 
particle size; therefore, F8 with high particle size demonstrated 
lower values of %P48 than SOD solution.  
- Comparison between hairy and non-hairy guinea pig with a 
synthetic membrane 
-Hairy skin: No significant difference was found between %P1 
obtained for SOD solution after application on hairy guinea pig skin 
and synthetic membrane. However, for %P48, this difference was 
significant with higher values obtained for synthetic membrane. 
Both niosomal formulations provided more %P1 and %P48 in hairy 
guinea pig skin than synthetic membrane. This finding confirmed the 
role of sebum in SOD-loaded niosome penetration through the 
follicular pathway. On the other hand, %P1 and %P48 provided after 
application of both niosomal formulations on hairy guinea pig skin 
were significantly different from these values obtained for SOD 
solution. This finding correlates well with results published by 
Blume-Peytavi et al. [41] who pointed out the role of sebum on drug 
delivery via hair follicles. 
-Non-hairy skin: The permeability of SOD through the synthetic 
membrane was more than non-hairy guinea pig skin when SOD 
solution and both niosomal formulations were applied.  
-The activity of SOD after application on hairy and non-hairy skins 
Both formulations demonstrated more SOD activity after application 
on guinea pig skins more than free-SOD. But no significant difference 
was found between hairy and non-hairy guinea pig skins (table 4). 
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Previously we reported that solid lipid nanoparticles increased SOD 
activity in the burned rat skin [43]. It seems that lipid carriers such 
as niosomes and solid lipid carrier area good carrier for SOD that 
protects enzyme activity and increases localization into the skin.
  
Table 4: The enzyme activity of protein permeated through different membranes after 1 and 48 h [mean±SD, n=5] 
Formulation  Hairy guinea pig skin Non-hairy guinea pig skin 
%A1 %A48 %A1 %A48 
Formulation 1 20.3±1.5 68.5±6.7 15.2±1.7 64.5±5.9 
Formulation 8 23.2±2.5 67.9±5.6 13.3±1.5 53.5±5.7 
Free-SOD  ND 50.2±3.9 2.5±0.2 41.5±4 
 %A1= enzyme activity due to protein permeated through a membrane after 1 h, %A48= enzyme activity due to protein permeated through a 







3: Permeation of free SOD aqueous solution (Free-SOD) and SOD-loaded in formulations 1 (F1) and 8 (F8) across the hairy skin, lipid 
extracted hairy skin (Lip-Ext hairy skin), non-hairy skin, lipid extracted non-hairy skin (Lip-Ext non-hairy skin), synthetic membrane 
(Synthetic) 
Niosome stability  
Niosome size, SOD content, SOD activity, and dispersion appearance 
were evaluated after 6 mo of storage at 2-8°C as indicators of 
formulation stability. Fig. 4 shows the AFM picture of niosome 
suspension immediately after preparation (fig. 4A) and six months 
of storage at 2-8°C (fig. B). Results indicated no significant particle 
size growth. Niosomes in both cases were spherical with a little 
extension on the surface that previously has been attributed to drug 
crystals on the surface of niosomes [44]. Moreover, after six months 
SOD content and activity decreased less than 5% and dispersion 
appearance did not change. Therefore, the prepared niosomal 
formulations were characterized as stable dispersions that 
protected the enzyme from degradation. Previously, Manca et al. 
evaluated the vesicle stability by AFM visualization technique and 
particle size analyzer [45, 46]. 
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Fig. 4: AFM images of niosomal formulation immediately after preparation (A) and after 6 mo of storage at 2-8°C (B) 
 
CONCLUSION 
Niosomes demonstrated stable vehicle for SOD loading that 
preserved enzyme activity. More than 90% of total SOD was 
encapsulated into the niosomes made by labrafil as a non-ionic 
surfactant. Type of surfactant played a critical role in niosomes 
characters. Niosomes prepared by labrafil indicated lower particle 
size and zeta potential that niosomes made by SLS as an anionic 
surfactant. SOD permeated through the skin mainly by a follicular 
pathway that niosomes made by both surfactants increased the 
affinity of SOD for the follicular pathway and induce high enzyme 
activity across the hair shaft. Niosome low particle size and 
interaction with the sebum were the main reason for increasing SOD 
affinity to follicular root. In conclusion, niosomes illustrated good 
properties as SOD follicular delivery systems that protected SOD 
against degradation and increased enzyme affinity to follicular root 
that is the site of action in alopecia aretea localization in the site of 
action.  
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